Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;95:568-571

This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cerbai, E.
Right arrow Articles by Mugelli, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cerbai, E.
Right arrow Articles by Mugelli, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Failure
Hazardous Substances DB
*POTASSIUM

(Circulation. 1997;95:568-571.)
© 1997 American Heart Association, Inc.


Articles

Characterization of the Hyperpolarization-Activated Current, If, in Ventricular Myocytes From Human Failing Heart

Elisabetta Cerbai, PhD; Roberto Pino, PhD; Francesco Porciatti, PhD; Guido Sani, MD; Michele Toscano, MD; Massimo Maccherini, MD; Gabriele Giunti, MD; Alessandro Mugelli, MD

the Department of Pharmacology, University of Firenze (E.C., R.P., F.P., A.M.); Cardiosurgery, University of Cagliari (G.S.); and Institute of Thoracic and Cardiovascular Surgery, University of Siena (M.T., M.M., G.G.), Italy.

Correspondence to Alessandro Mugelli, MD, Department of Preclinical and Clinical Pharmacology, University of Firenze, Viale G.B. Morgagni 65, 50134 Firenze, Italy. E-mail mugelli@stat.ds.unifi.it.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background Disease-associated electrophysiological alterations may contribute to the increased predisposition to arrhythmias of the hypertrophied or failing myocardium. An If-like current is expressed in rat left ventricular myocytes (LVMs), its amplitude being linearly related to the severity of cardiac hypertrophy. Here, we report the occurrence and electrophysiological properties of If in human LVMs.

Methods and Results LVMs were isolated from hearts of three male patients undergoing cardiac transplantation for terminal heart failure due to ischemic dilated cardiomyopathy. The patch-clamp technique was used to record If, ie, a barium-insensitive, cesium-sensitive, time-dependent increasing inward current elicited on hyperpolarization. Membrane capacitance was 244±27 pF (n=25). If occurred in all cells tested; its density measured at -120 mV was 2.1±0.3 pA/pF. Activation curves of If (n=24) were fitted by a Boltzmann function; the threshold was -55 mV; midpoint, -70.9±2.1 mV; slope, -5.4±0.3 mV; and maximal specific conductance, 19.6±2.5 pS/pF. If blockade by extracellular cesium was voltage dependent. Reducing extracellular potassium concentration from 25 to 5.4 mmol/L caused a shift of the reversal potential from -12.7±0.5 to -24.8±2.1 mV and a 64% decrease of current conductance.

Conclusions If is present in human LVMs. Its electrophysiological characteristics resemble those previously described in hypertrophied rat LVMs and suggest that If could be an arrhythmogenic mechanism in patients with severe heart failure.


Key Words: arrhythmia • electrophysiology • myocytes • heart failure • hypertrophy


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Mortality in heart failure patients is high. About half of the deaths are sudden and unexpected.1 Apart from the high incidence of sudden death, patients with heart failure often experience ventricular arrhythmias.2 3 Occurrence of ventricular arrhythmias and incidence of sudden death are likely to be related. Many changes, eg, fibrosis, loss of viable myocytes, and dispersion of refractoriness, that occur in the hypertrophied heart are likely to predispose to arrhythmias.4 Recent studies have documented that the electrophysiological properties of cardiac cells are altered in disease. Action potentials of ventricular myocytes isolated from patients with congestive cardiomyopathy are prolonged.5 The underlying ionic mechanism appears to be a decrease in Ito.6 Prolongation of action potential duration and reduction of Ito have been reported in hypertrophied myocytes isolated from the hearts of SHRs.7 The similarities of the alterations found led us to consider the SHR a useful and predictive model for cardiac hypertrophy due to pressure overload and for its transition to failure.8 In >90% of myocytes isolated from the left ventricle of old SHRs (ie, hearts with severe hypertrophy), we previously demonstrated the presence of a time-dependent inward current, activated by hyperpolarization and having the properties of the If.9 If is a cesium-sensitive, barium-insensitive inward current generally thought to be present only in primary or secondary pacemakers, in which it might contribute to diastolic depolarization.10 More recently, we found that If density in ventricular myocytes can be linearly related to the severity of cardiac hypertrophy.11 In SHRs with signs of heart failure, the amplitude of If was even larger.12 Furthermore, If amplitude was increased by ß-adrenergic stimulation by shifting of its activation curve toward less negative potentials.11 Because our previous results were suggestive of a contribution of If to the increased propensity for ventricular arrhythmias of the hypertrophied and failing (rat) heart, we assessed the presence of If in human ventricular myocytes. Here, we report that a current with the electrophysiological properties of If is consistently present in human ventricular myocytes isolated from three patients with postischemic dilated cardiomyopathy undergoing heart transplantation.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Preparation of Single Ventricular Myocytes
The hearts were obtained from three male patients undergoing cardiac transplantation for terminal heart failure due to ischemic cardiomyopathy; informed consent was obtained before heart transplantation. The patients chosen for this study were homogeneous for age (61 to 62 years) and dimension of the left ventricle (left ventricular diastolic diameter, 69 to 73 mm). All patients received digoxin and diuretics and were taking vasodilator therapy; therapy was discontinued 6 hours before the intervention. After explantation, a portion of the left ventricle was cut and transported to the laboratory in cold (4°C) cardioplegic solution. The procedure for cell isolation was similar to that described by Veldkamp et al.13 A portion of the free wall with a visible coronary artery was chosen and perfused through this arterial branch with LCS for 20 minutes and then with LCS containing 0.15 mg/mL collagenase B and 0.1 mg/mL collagenase P (both Boehringer Mannheim) for 25 minutes. The tissue that appeared clearly digested was cut into small pieces that were stirred in a bottle containing Kraftbruhe solution.13 14 The temperature of all perfusing solutions was 35°C. Cells were collected and allowed to sediment, the pellet was then resuspended in LCS, and Ca2+ concentration was gradually increased up to 0.5 mmol/L. The yield of viable cells was 5% to 8%.

Solutions and Reagents
The composition of the solutions (in mmol/L) was as follows: cardioplegic solution: NaCl 82, KCl 20, CaSO4 0.5, MgSO4 7.5, NaHCO3 23, glucose 25, and mannitol 55; LCS: NaCl 140, KCl 5.4, MgCl2 0.5, KH2PO4 1.2, glucose 5.5, and HEPES 5, pH 6.9 with NaOH; and control Tyrode's solution: NaCl 137, KCl 5.4, CaCl2 1.5, MgCl2 1.2, HEPES 5, and glucose 10, pH 7.35 with NaOH. To study If, the control solution was modified to reduce the interference of other currents9 11 by addition of (in mmol/L) BaCl2 2, MnCl2 2, CdCl2 0.2, and 4-aminopyridine 0.5; [K+]o was increased to 25 mmol/L (unless indicated). Pipette solution contained (in mmol/L): potassium aspartate 130, MgCl2 2, Na2-ATP 5, CaCl2 5, EGTA 11, and HEPES 10; pH 7.2 with KOH. The liquid junction potential between the electrode tip and the extracellular solution was not corrected.9 11

Recording Techniques
Cells were transferred to a recording chamber mounted on the stage of an inverted microscope (Nikon Diaphot) and superfused by gravity with a six-line microperfusor system placed near the cell at a flow rate of 1 mL/min (temperature, 36°C). The experimental setup used for patch-clamp recording in the whole-cell configuration was similar to that described previously.9 11 Cm was measured by ±10-mV voltage steps applied from a holding potential of -70 mV and calculated as described previously9 11 ; no capacitance correction was used. The cutoff frequency was 10 kHz. If was elicited by hyperpolarizing steps applied at low frequency (maximum rate, 0.1 Hz); because of its slow activation kinetics, If was sampled at 0.5 to 1 kHz.

Data Analysis
The amplitude of If was measured as the difference between the instantaneous current at the beginning of the hyperpolarizing step and the steady-state current recorded at the end of the step and normalized to Cm. From the I-V relations, specific conductance of If was determined for each cell according to the equation g=I/(Vm-Vrev), where g is the conductance calculated at membrane potential Vm, I the current amplitude, and Vrev is calculated from the analysis of tail currents. gmax was obtained by fitting values with the Boltzmann function: g=gmax/{1+exp[(VH-Vm)/k]}, where k is the slope factor describing the steepness of the activation curve. Vrev was derived from tail-current analysis by fitting a linear relationship to the fully activated I-V relation of If performed at 5.4 or 25 mmol/L [K+]o.9 11 All data are presented as mean±SEM.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Twenty-five cells isolated from three patients undergoing heart transplantation for terminal heart failure due to postischemic dilated cardiomyopathy were studied. Membrane capacitance, an index of cell dimensions, was 244±27 pF. As detailed in "Methods," voltage-clamp experiments were performed with a modified Tyrode's solution to amplify If and to reduce overlapping inward and outward currents. We considered If to be present when a hyperpolarizing step to -120 mV from the holding potential (-40 mV) elicited a time-dependent increasing inward current that was blocked by addition of 4 mmol/L CsCl. If occurred in all cells tested (n=25); the density of the current measured at -120 mV was 2.1±0.3 pA/pF. Fig 1aDown shows representative traces of If recorded during hyperpolarizing steps to increasing negative potentials (-50 to -110 mV). The duration of the step was decreased (from 3200 to 2000 ms) as the activation of the current became progressively faster.



View larger version (21K):
[in this window]
[in a new window]
 
Figure 1. Voltage dependence of If in human ventricular myocytes. a, Representative current recordings elicited by hyperpolarizing voltage pulses between -50 and -110 mV in steps of 10 mV, according to the protocol drawn at the bottom (Cm=278 pF). b, Plot of mean specific conductance (gf) vs step potential (n=24). Curve was fitted to data points by a Boltzmann distribution. c, Plot of time-constant reciprocals (obtained by fitting exponential curves to If activation in 24 cells) vs membrane potential. Line is theoretical curve obtained by fitting mean data points with the function 1/{tau}=exp(-2.9-0.04xVm)+exp(3.6+0.11xVm).

Mean current specific conductance normalized to Cm was plotted as a function of the hyperpolarizing step potential (Fig 1bUp). The experimental points were fitted by a Boltzmann function; the average activation curve (represented by the line of Fig 1bUp), obtained from 24 individual curves, showed a threshold at approximately -55 mV, VH at -70.9±2.1 mV, slope of -5.4±0.3 mV, and gmax of 19.6±2.5 pS/pF. Time-constant reciprocals obtained by single exponential fitting of individual current traces were reported as a function of the step voltage (Fig 1cUp): it clearly appears that the rate of current onset increases at larger hyperpolarizations. The line represents the theoretical curve obtained by fitting experimental data points with a function describing a first-order Hodgkin-Huxley kinetics.15

Effect of Extracellular Cesium and Potassium
The effect of cesium, which is a widely used tool to block If,9 was evaluated over a large range of potentials (-70 to +10 mV) by measurement of the amplitude of tail currents after a hyperpolarizing step to -120 mV, which fully activates If. The results of such an experiment are shown in Fig 2Down. Current traces recorded in the absence and presence of 4 mmol/L CsCl are shown (a). Addition of cesium resulted in an almost complete block of the inward current elicited by the step at -120 mV and markedly reduced tail inward currents at -50 mV but did not modify outward currents at +10 mV. In Fig 2bDown, tail-current amplitude normalized to Cm was plotted against the step voltage; in controls, fitting of data points gave a linear relationship similar to that previously reported in rat ventricular myocytes,9 11 with a slope conductance of 21.9±2.9 pS/pF and extrapolated Vrev of -13.1±1.2 mV (n=18). In the presence of cesium, the negative region of the fully activated I-V relationship was characterized by a progressive reduction of the current, showing a clear-cut voltage-dependent blockade. Vrev in the presence of cesium was -11.9±2.7 mV (n=4), a figure not different from that measured in control conditions.



View larger version (19K):
[in this window]
[in a new window]
 
Figure 2. Effect of cesium and [K+]o on If. a, Current traces recorded in the absence ({circ}) and presence ({bullet}) of 4 mmol/L CsCl during hyperpolarization to -120 mV and after return to -50 or +10 mV. b, Plot of tail current amplitude, normalized to Cm (332 pF), vs voltage. c, Representative currents recorded in same cell (Cm=116 pF) superfused with 25 ({circ}) or 5.4 ({bullet}) mmol/L [K+]o during hyperpolarization to -120 mV and after return to -20 mV. Note that small tail current is inward at 25 mmol/L [K+]o and outward at 5.4 mmol/L [K+]o. d, Plot of tail current amplitude, normalized to Cm, vs tail step potential (n=3). Lines are results of best linear fitting to experimental data.

The measurement of tail-current amplitude was used to evaluate Vrev of If at different [K+]o. Tail currents, after a hyperpolarizing step to -120 mV, which maximally activates If, were elicited by steps in the range of -70 to +10 mV. Current tracings in Fig 2cUp were obtained in the same cell superfused with Tyrode's solution containing either 25 or 5.4 mmol/L [K+]o. The most evident effect caused by the reduction in [K+]o was a marked decrease in If amplitude. Fig 2dUp shows a fully activated I-V relationship obtained from three cells exposed to different [K+]o; tail-current amplitude was normalized to Cm. With 25 mmol/L [K+]o, the best fit through data points gave a linear relationship, with a slope of 37.7±9.3 pS/pF, which intersected the x axis (Vrev) at -12.7±0.5 mV (n=3). With 5.4 mmol/L [K+]o, Vrev was shifted to more negative potentials (-24.8±2.1 mV) and the slope was reduced by 64% (13.4±5.4 pS/pF, n=3), in agreement with our previous results in hypertrophied rat myocytes.9 11


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
In the present study, we demonstrate the presence of If in human ventricular myocytes and describe its electrophysiological properties. The presence of this current in human ventricular myocytes has been reported only in abstract form.16 We previously demonstrated that a current having the properties of If is present in hypertrophied rat ventricular myocytes and that its amplitude is related to the degree of hypertrophy, its density being larger as the severity of myocardial hypertrophy increases9 11 ; other factors, such as cell dimensions or age, are likely to be involved.11 For these reasons, we wanted to assess the presence and properties of If in human ventricular myocytes isolated from patients as homogeneous as possible. Each of the three patients had heart failure due to ischemic cardiomyopathy, similar age, and comparable dilatation of the left ventricle. Myocytes isolated from the hearts of these patients had similar capacitances and consistently showed the occurrence of If. The electrophysiological characteristics of If turned out to be very similar to those previously described for If recorded in hypertrophied rat ventricular myocytes: the threshold of activation was at about -55 mV and the midpoint around -70 mV, voltages that most likely approximate the diastolic potential of these cells. The current was fully activated at -120 mV; its density was 2.1±0.3 pA/pF; and it was barium insensitive and blocked by extracellular cesium. Its reversal potential was consistent with selectivity for Na+ and K+: PNa/PK calculated from Vrev values is 0.42±0.03 (n=18) and 0.36±0.03 (n=3) at 25 and 5.4 mmol/L [K+]o, respectively. Thus, the current has the properties (ie, voltage dependence, cesium sensitivity, permeability ratio) of If recorded in primary and secondary pacemaker cells.10 Obviously, further studies are necessary to better understand the factors controlling its development or its functional role in human myocytes. Results obtained in myocytes from undiseased donor hearts16 suggest that its amplitude at -120 mV is much smaller, as was also found in normal rat myocytes.9 11 If the current density is modulated by disease in humans as in rats,11 it is possible to speculate that its relevance may increase in the failing heart. As we have previously hypothesized for the hypertrophied rat heart, it can be speculated that If might represent an important arrhythmogenic mechanism in patients with severe heart failure. Both automaticity and delayed afterdepolarizations are observed in ventricular trabeculae of failing human myocardium exposed to an altered extracellular environment mimicking that present in patients with heart failure.17 These alterations cannot explain the rapid ventricular tachycardias occurring in heart failure; however, they may induce extrasystoles, which can serve as a trigger in hearts in which the substrate for reentry is clearly present. It is not unreasonable to imagine that If could interact with other inward currents, such as the transient inward current underlying delayed afterdepolarizations, eventually bringing to threshold some subthreshold delayed afterdepolarizations and thus favoring the appearance of arrhythmias in the failing heart.


*    Selected Abbreviations and Acronyms
 
Cm = membrane capacitance
gmax = maximal specific conductance
I-V = current-voltage
If = pacemaker current (hyperpolarization-activated current)
Ito = transient outward current
[K+]o = extracellular potassium concentration
LCS = low-calcium solution
SHR = spontaneously hypertensive rat
VH = voltage of half-maximal activation of If
Vrev = reversal potential of If


*    Acknowledgments
 
This work was supported by a grant from Telethon (project No. 709).

Received October 15, 1996; revision received November 27, 1996; accepted December 2, 1996.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 

  1. Kannel WB, Plehn JF, Cupples LA. Cardiac failure and sudden death in the Framingham study. Am Heart J. 1988;115:869-875.[Medline] [Order article via Infotrieve]
  2. Messerli FH, Ventura HO, Elilardi DJ, Dunn FG, Frohlich ED. Hypertension and sudden death: increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med. 1984;77:18-22.[Medline] [Order article via Infotrieve]
  3. Levy D, Anderson K, Savage DD, Balkus SA, Kannel WB, Castelli WP. Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol. 1987;60:560-565.[Medline] [Order article via Infotrieve]
  4. Pye MP, Cobbe SM. Mechanisms of ventricular arrhythmias in cardiac failure and hypertrophy. Cardiovasc Res. 1992;26:740-750.[Free Full Text]
  5. Tomaselli GF, Beuckelmann DJ, Calkins HG, Berger RD, Kessler PD, Lawrence JH, Kass D, Feldman AM, Marban E. Sudden cardiac death in heart failure: the role of abnormal repolarization. Circulation. 1994;90:2534-2539.[Abstract/Free Full Text]
  6. Beuckelmann DJ, Nabauer M, Erdmann E. Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res. 1993;73:379-385.[Abstract/Free Full Text]
  7. Cerbai E, Barbieri M, Li Q, Mugelli A. Ionic basis of action potential prolongation of hypertrophied myocytes isolated from the heart of hypertensive rats of different ages. Cardiovasc Res. 1994;28:1180-1187.[Abstract/Free Full Text]
  8. Bing OHL, Brooks WW, Robinson KG, Slawsky MT, Hayes JA, Litwin SE, Sen S, Conrad CH. The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure. J Mol Cell Cardiol. 1995;27:383-396.[Medline] [Order article via Infotrieve]
  9. Cerbai E, Barbieri M, Mugelli A. Characterization of the hyperpolarization-activated current, If, in ventricular myocytes isolated from hypertensive rats. J Physiol (Lond). 1994;481.3:585-591.
  10. Di Francesco D. Pacemaker mechanisms in cardiac tissue. Annu Rev Physiol. 1993;55:455-472.[Medline] [Order article via Infotrieve]
  11. Cerbai E, Barbieri M, Mugelli A. Occurrence and properties of the hyperpolarization-activated current, If, in ventricular myocytes from normotensive and hypertensive rats during aging. Circulation. 1996;94:1674-1681.[Abstract/Free Full Text]
  12. Cerbai E, Barbieri M, Porciatti F, Mugelli A. Ionic channels in hypertrophy and heart failure: relevance for arrhythmogenesis. New Trends Arrhythmia. 1995;9:135-139.
  13. Veldkamp MW, van Ginneken ACG, Opthof T, Bouman LN. Delayed rectifier channels in human ventricular myocytes. Circulation. 1995;92:3497-3504.[Abstract/Free Full Text]
  14. Isenberg G, Klockner U. Calcium tolerant ventricular myocytes prepared by preincubation in a `KB' medium. Pflugers Arch. 1982;395:6-18.[Medline] [Order article via Infotrieve]
  15. DiFrancesco D. Characterization of the pacemaker current kinetics in calf Purkinje fibres. J Physiol (Lond). 1984;348:341-367.[Abstract/Free Full Text]
  16. Beuckelman DJ, Jansen E, Erdmann E. A pacemaker current is expressed in isolated ventricular myocytes from patients with heart failure. Circulation. 1995;92(suppl I):I-505. Abstract.
  17. Vermeulen JT, McGuire MA, Opthof T, Coronel R, de Bakker JMT, Klopping C, Janse MJ. Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts. Cardiovasc Res. 1994;28:1547-1554.[Medline] [Order article via Infotrieve]



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
X. Luo, H. Lin, Z. Pan, J. Xiao, Y. Zhang, Y. Lu, B. Yang, and Z. Wang
Down-regulation of miR-1/miR-133 Contributes to Re-expression of Pacemaker Channel Genes HCN2 and HCN4 in Hypertrophic Heart
J. Biol. Chem., July 18, 2008; 283(29): 20045 - 20052.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Michels, M. C. Brandt, N. Zagidullin, I. F. Khan, R. Larbig, S. van Aaken, J. Wippermann, and U. C. Hoppe
Direct evidence for calcium conductance of hyperpolarization-activated cyclic nucleotide-gated channels and human native If at physiological calcium concentrations
Cardiovasc Res, June 1, 2008; 78(3): 466 - 475.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. P. Ye, S. Z. Duan, D. S. Milstone, and R. M. Mortensen
Go controls the hyperpolarization-activated current in embryonic stem cell-derived cardiocytes
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H979 - H985.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Muto, N. Ueda, T. Opthof, T. Ohkusa, K. Nagata, S. Suzuki, Y. Tsuji, M. Horiba, J.-K. Lee, H. Honjo, et al.
Aldosterone modulates If current through gene expression in cultured neonatal rat ventricular myocytes
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2710 - H2718.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Cheng, K. Kinard, R. Rajamani, and M. C. Sanguinetti
Molecular Mapping of the Binding Site for a Blocker of Hyperpolarization-Activated, Cyclic Nucleotide-Modulated Pacemaker Channels
J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 931 - 939.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
L. Sartiani, E. Bettiol, F. Stillitano, A. Mugelli, E. Cerbai, and M. E. Jaconi
Developmental Changes in Cardiomyocytes Differentiated from Human Embryonic Stem Cells: A Molecular and Electrophysiological Approach
Stem Cells, May 1, 2007; 25(5): 1136 - 1144.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Physiol.Home page
P. Pian, A. Bucchi, R. B. Robinson, and S. A. Siegelbaum
Regulation of Gating and Rundown of HCN Hyperpolarization-activated Channels by Exogenous and Endogenous PIP2
J. Gen. Physiol., November 1, 2006; 128(5): 593 - 604.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Sridhar, S. J. Dech, V. A. Lacombe, T. S. Elton, S. A. McCune, R. A. Altschuld, and C. A. Carnes
Abnormal diastolic currents in ventricular myocytes from spontaneous hypertensive heart failure rats
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2192 - H2198.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Kashiwakura, H. C. Cho, A. S. Barth, E. Azene, and E. Marban
Gene Transfer of a Synthetic Pacemaker Channel Into the Heart: A Novel Strategy for Biological Pacing
Circulation, October 17, 2006; 114(16): 1682 - 1686.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Michels, F. Er, I. Khan, M. Sudkamp, S. Herzig, and U. C. Hoppe
Single-Channel Properties Support a Potential Contribution of Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels and If to Cardiac Arrhythmias
Circulation, February 1, 2005; 111(4): 399 - 404.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Zorn-Pauly, P. Schaffer, B. Pelzmann, P. Lang, H. Machler, B. Rigler, and B. Koidl
If in left human atrium: a potential contributor to atrial ectopy
Cardiovasc Res, November 1, 2004; 64(2): 250 - 259.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Er, R. Larbig, A. Ludwig, M. Biel, F. Hofmann, D. J. Beuckelmann, and U. C. Hoppe
Dominant-Negative Suppression of HCN Channels Markedly Reduces the Native Pacemaker Current If and Undermines Spontaneous Beating of Neonatal Cardiomyocytes
Circulation, January 28, 2003; 107(3): 485 - 489.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Han, L. Zhang, G. Schram, and S. Nattel
Properties of potassium currents in Purkinje cells of failing human hearts
Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2495 - H2503.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Xue, E. Marban, and R. A. Li
Dominant-Negative Suppression of HCN1- and HCN2-Encoded Pacemaker Currents by an Engineered HCN1 Construct: Insights Into Structure-Function Relationships and Multimerization
Circ. Res., June 28, 2002; 90(12): 1267 - 1273.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y.-C. Chen, S.-A. Chen, Y.-J. Chen, M.-S. Chang, P. Chan, and C.-I. Lin
Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes
J. Am. Coll. Cardiol., January 16, 2002; 39(2): 366 - 372.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. M Bryant, C. E Sears, L. Rigg, D. A Terrar, and B. Casadei
Nitric oxide does not modulate the hyperpolarization-activated current, If, in ventricular myocytes from spontaneously hypertensive rats
Cardiovasc Res, July 1, 2001; 51(1): 51 - 58.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Yasui, W. Liu, T. Opthof, K. Kada, J.-K. Lee, K. Kamiya, and I. Kodama
If Current and Spontaneous Activity in Mouse Embryonic Ventricular Myocytes
Circ. Res., March 16, 2001; 88(5): 536 - 542.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Stilli, A. Sgoifo, E. Macchi, M. Zaniboni, S. De Iasio, E. Cerbai, A. Mugelli, C. Lagrasta, G. Olivetti, and E. Musso
Myocardial remodeling and arrhythmogenesis in moderate cardiac hypertrophy in rats
Am J Physiol Heart Circ Physiol, January 1, 2001; 280(1): H142 - H150.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. Cerbai, A. Crucitti, L. Sartiani, P. De Paoli, R. Pino, M. L. Rodriguez, G. Gensini, and A. Mugelli
Long-term treatment of spontaneously hypertensive rats with losartan and electrophysiological remodeling of cardiac myocytes
Cardiovasc Res, January 14, 2000; 45(2): 388 - 396.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Menard, S. Pupier, D. Mornet, M. Kitzmann, J. Nargeot, and P. Lory
Modulation of L-type Calcium Channel Expression during Retinoic Acid-induced Differentiation of H9C2 Cardiac Cells
J. Biol. Chem., October 8, 1999; 274(41): 29063 - 29070.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Schaffer, B. Pelzmann, E. Bernhart, P. Lang, H. Machler, B. Rigler, and B. Koidl
Repolarizing currents in ventricular myocytes from young patients with tetralogy of Fallot
Cardiovasc Res, August 1, 1999; 43(2): 332 - 343.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. F. Tomaselli and E. Marban
Electrophysiological remodeling in hypertrophy and heart failure
Cardiovasc Res, May 1, 1999; 42(2): 270 - 283.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. Cerbai, R. Pino, L. Sartiani, and A. Mugelli
Influence of postnatal-development on If occurrence and properties in neonatal rat ventricular myocytes
Cardiovasc Res, May 1, 1999; 42(2): 416 - 423.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. Cerbai, R. Pino, M. L Rodriguez, and A. Mugelli
Modulation of the pacemaker current If by {beta}-adrenoceptor subtypes in ventricular myocytes isolated from hypertensive and normotensive rats
Cardiovasc Res, April 1, 1999; 42(1): 121 - 129.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Pino, E. Cerbai, G. Calamai, F. Alajmo, A. Borgioli, L. Braconi, M. Cassai, G. F. Montesi, and A. Mugelli
Effect of 5-HT4 receptor stimulation on the pacemaker current If in human isolated atrial myocytes
Cardiovasc Res, December 1, 1998; 40(3): 516 - 522.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
U. C Hoppe and D. J Beuckelmann
Characterization of the hyperpolarization-activated inward current in isolated human atrial myocytes
Cardiovasc Res, June 1, 1998; 38(3): 788 - 801.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
U. C. Hoppe, E. Jansen, M. Sudkamp, and D. J. Beuckelmann
Hyperpolarization-Activated Inward Current in Ventricular Myocytes From Normal and Failing Human Hearts
Circulation, January 13, 1998; 97(1): 55 - 65.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. Musialek, M. Lei, H. F. Brown, D. J. Paterson, and B. Casadei
Nitric Oxide Can Increase Heart Rate by Stimulating the Hyperpolarization-Activated Inward Current, If
Circ. Res., July 19, 1997; 81(1): 60 - 68.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cerbai, E.
Right arrow Articles by Mugelli, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cerbai, E.
Right arrow Articles by Mugelli, A.
<